ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vaccines For Children (VFC) Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-32J7852
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Vaccines For Children VFC Market Insights and Forecast to 2028
BUY CHAPTERS

Global Vaccines For Children (VFC) Market Research Report 2025

Code: QYRE-Auto-32J7852
Report
July 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GSK
Sanofi
Merck
Pfizer Inc
Jintan
CSL Limited
MedImmune
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
J&J(Crucell)

Vaccines For Children (VFC) Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Vaccines For Children (VFC) Market

Vaccines For Children (VFC) Market

The global market for Vaccines For Children (VFC) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vaccines For Children (VFC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines For Children (VFC).
The Vaccines For Children (VFC) market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vaccines For Children (VFC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccines For Children (VFC) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Vaccines For Children (VFC) Market Report

Report Metric Details
Report Name Vaccines For Children (VFC) Market
CAGR 5%
Segment by Type
Segment by Application
  • Government Institution
  • Private Sector
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GSK, Sanofi, Merck, Pfizer, Jintan, CSL, MedImmune LLC, J&J(Crucell), China National Biotec, Tiantan, Hualan, Kangtai, Hissen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Vaccines For Children (VFC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Vaccines For Children (VFC) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Vaccines For Children (VFC) Market report?

Ans: The main players in the Vaccines For Children (VFC) Market are GSK, Sanofi, Merck, Pfizer, Jintan, CSL, MedImmune LLC, J&J(Crucell), China National Biotec, Tiantan, Hualan, Kangtai, Hissen

What are the Application segmentation covered in the Vaccines For Children (VFC) Market report?

Ans: The Applications covered in the Vaccines For Children (VFC) Market report are Government Institution, Private Sector, Other

What are the Type segmentation covered in the Vaccines For Children (VFC) Market report?

Ans: The Types covered in the Vaccines For Children (VFC) Market report are Recombinant Vaccines, Viral Vaccines, Polysaccharide Vaccines, Others

Recommended Reports

Child Vaccines

Vaccine Ancillaries

Specialty Vaccines

1 Vaccines For Children (VFC) Market Overview
1.1 Product Definition
1.2 Vaccines For Children (VFC) by Type
1.2.1 Global Vaccines For Children (VFC) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Recombinant Vaccines
1.2.3 Viral Vaccines
1.2.4 Polysaccharide Vaccines
1.2.5 Others
1.3 Vaccines For Children (VFC) by Application
1.3.1 Global Vaccines For Children (VFC) Market Value by Application (2024 VS 2031)
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global Vaccines For Children (VFC) Market Size Estimates and Forecasts
1.4.1 Global Vaccines For Children (VFC) Revenue 2020-2031
1.4.2 Global Vaccines For Children (VFC) Sales 2020-2031
1.4.3 Global Vaccines For Children (VFC) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Vaccines For Children (VFC) Market Competition by Manufacturers
2.1 Global Vaccines For Children (VFC) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Vaccines For Children (VFC) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Vaccines For Children (VFC) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Vaccines For Children (VFC), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccines For Children (VFC), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccines For Children (VFC), Product Type & Application
2.7 Global Key Manufacturers of Vaccines For Children (VFC), Date of Enter into This Industry
2.8 Global Vaccines For Children (VFC) Market Competitive Situation and Trends
2.8.1 Global Vaccines For Children (VFC) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Vaccines For Children (VFC) Players Market Share by Revenue
2.8.3 Global Vaccines For Children (VFC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vaccines For Children (VFC) Market Scenario by Region
3.1 Global Vaccines For Children (VFC) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Vaccines For Children (VFC) Sales by Region: 2020-2031
3.2.1 Global Vaccines For Children (VFC) Sales by Region: 2020-2025
3.2.2 Global Vaccines For Children (VFC) Sales by Region: 2026-2031
3.3 Global Vaccines For Children (VFC) Revenue by Region: 2020-2031
3.3.1 Global Vaccines For Children (VFC) Revenue by Region: 2020-2025
3.3.2 Global Vaccines For Children (VFC) Revenue by Region: 2026-2031
3.4 North America Vaccines For Children (VFC) Market Facts & Figures by Country
3.4.1 North America Vaccines For Children (VFC) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Vaccines For Children (VFC) Sales by Country (2020-2031)
3.4.3 North America Vaccines For Children (VFC) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vaccines For Children (VFC) Market Facts & Figures by Country
3.5.1 Europe Vaccines For Children (VFC) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Vaccines For Children (VFC) Sales by Country (2020-2031)
3.5.3 Europe Vaccines For Children (VFC) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccines For Children (VFC) Market Facts & Figures by Region
3.6.1 Asia Pacific Vaccines For Children (VFC) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Vaccines For Children (VFC) Sales by Region (2020-2031)
3.6.3 Asia Pacific Vaccines For Children (VFC) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vaccines For Children (VFC) Market Facts & Figures by Country
3.7.1 Latin America Vaccines For Children (VFC) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Vaccines For Children (VFC) Sales by Country (2020-2031)
3.7.3 Latin America Vaccines For Children (VFC) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccines For Children (VFC) Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccines For Children (VFC) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Vaccines For Children (VFC) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Vaccines For Children (VFC) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaccines For Children (VFC) Sales by Type (2020-2031)
4.1.1 Global Vaccines For Children (VFC) Sales by Type (2020-2025)
4.1.2 Global Vaccines For Children (VFC) Sales by Type (2026-2031)
4.1.3 Global Vaccines For Children (VFC) Sales Market Share by Type (2020-2031)
4.2 Global Vaccines For Children (VFC) Revenue by Type (2020-2031)
4.2.1 Global Vaccines For Children (VFC) Revenue by Type (2020-2025)
4.2.2 Global Vaccines For Children (VFC) Revenue by Type (2026-2031)
4.2.3 Global Vaccines For Children (VFC) Revenue Market Share by Type (2020-2031)
4.3 Global Vaccines For Children (VFC) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Vaccines For Children (VFC) Sales by Application (2020-2031)
5.1.1 Global Vaccines For Children (VFC) Sales by Application (2020-2025)
5.1.2 Global Vaccines For Children (VFC) Sales by Application (2026-2031)
5.1.3 Global Vaccines For Children (VFC) Sales Market Share by Application (2020-2031)
5.2 Global Vaccines For Children (VFC) Revenue by Application (2020-2031)
5.2.1 Global Vaccines For Children (VFC) Revenue by Application (2020-2025)
5.2.2 Global Vaccines For Children (VFC) Revenue by Application (2026-2031)
5.2.3 Global Vaccines For Children (VFC) Revenue Market Share by Application (2020-2031)
5.3 Global Vaccines For Children (VFC) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Vaccines For Children (VFC) Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Vaccines For Children (VFC) Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Vaccines For Children (VFC) Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Vaccines For Children (VFC) Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Jintan
6.5.1 Jintan Company Information
6.5.2 Jintan Description and Business Overview
6.5.3 Jintan Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Jintan Vaccines For Children (VFC) Product Portfolio
6.5.5 Jintan Recent Developments/Updates
6.6 CSL
6.6.1 CSL Company Information
6.6.2 CSL Description and Business Overview
6.6.3 CSL Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CSL Vaccines For Children (VFC) Product Portfolio
6.6.5 CSL Recent Developments/Updates
6.7 MedImmune LLC
6.7.1 MedImmune LLC Company Information
6.7.2 MedImmune LLC Description and Business Overview
6.7.3 MedImmune LLC Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 MedImmune LLC Vaccines For Children (VFC) Product Portfolio
6.7.5 MedImmune LLC Recent Developments/Updates
6.8 J&J(Crucell)
6.8.1 J&J(Crucell) Company Information
6.8.2 J&J(Crucell) Description and Business Overview
6.8.3 J&J(Crucell) Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 J&J(Crucell) Vaccines For Children (VFC) Product Portfolio
6.8.5 J&J(Crucell) Recent Developments/Updates
6.9 China National Biotec
6.9.1 China National Biotec Company Information
6.9.2 China National Biotec Description and Business Overview
6.9.3 China National Biotec Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 China National Biotec Vaccines For Children (VFC) Product Portfolio
6.9.5 China National Biotec Recent Developments/Updates
6.10 Tiantan
6.10.1 Tiantan Company Information
6.10.2 Tiantan Description and Business Overview
6.10.3 Tiantan Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Tiantan Vaccines For Children (VFC) Product Portfolio
6.10.5 Tiantan Recent Developments/Updates
6.11 Hualan
6.11.1 Hualan Company Information
6.11.2 Hualan Description and Business Overview
6.11.3 Hualan Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hualan Vaccines For Children (VFC) Product Portfolio
6.11.5 Hualan Recent Developments/Updates
6.12 Kangtai
6.12.1 Kangtai Company Information
6.12.2 Kangtai Description and Business Overview
6.12.3 Kangtai Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Kangtai Vaccines For Children (VFC) Product Portfolio
6.12.5 Kangtai Recent Developments/Updates
6.13 Hissen
6.13.1 Hissen Company Information
6.13.2 Hissen Description and Business Overview
6.13.3 Hissen Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hissen Vaccines For Children (VFC) Product Portfolio
6.13.5 Hissen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccines For Children (VFC) Industry Chain Analysis
7.2 Vaccines For Children (VFC) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccines For Children (VFC) Production Mode & Process Analysis
7.4 Vaccines For Children (VFC) Sales and Marketing
7.4.1 Vaccines For Children (VFC) Sales Channels
7.4.2 Vaccines For Children (VFC) Distributors
7.5 Vaccines For Children (VFC) Customer Analysis
8 Vaccines For Children (VFC) Market Dynamics
8.1 Vaccines For Children (VFC) Industry Trends
8.2 Vaccines For Children (VFC) Market Drivers
8.3 Vaccines For Children (VFC) Market Challenges
8.4 Vaccines For Children (VFC) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GSK
Sanofi
Merck
Pfizer Inc
Jintan
CSL Limited
MedImmune
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
J&J(Crucell)
List of Tables
 Table 1. Global Vaccines For Children (VFC) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Vaccines For Children (VFC) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Vaccines For Children (VFC) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Vaccines For Children (VFC) Sales (K Doses) of Key Manufacturers (2020-2025)
 Table 5. Global Vaccines For Children (VFC) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Vaccines For Children (VFC) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Vaccines For Children (VFC) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Vaccines For Children (VFC) Average Price (US$/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Vaccines For Children (VFC), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Vaccines For Children (VFC), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Vaccines For Children (VFC), Product Type & Application
 Table 12. Global Key Manufacturers of Vaccines For Children (VFC), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Vaccines For Children (VFC) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines For Children (VFC) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Vaccines For Children (VFC) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Vaccines For Children (VFC) Sales by Region (2020-2025) & (K Doses)
 Table 18. Global Vaccines For Children (VFC) Sales Market Share by Region (2020-2025)
 Table 19. Global Vaccines For Children (VFC) Sales by Region (2026-2031) & (K Doses)
 Table 20. Global Vaccines For Children (VFC) Sales Market Share by Region (2026-2031)
 Table 21. Global Vaccines For Children (VFC) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Vaccines For Children (VFC) Revenue Market Share by Region (2020-2025)
 Table 23. Global Vaccines For Children (VFC) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Vaccines For Children (VFC) Revenue Market Share by Region (2026-2031)
 Table 25. North America Vaccines For Children (VFC) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Vaccines For Children (VFC) Sales by Country (2020-2025) & (K Doses)
 Table 27. North America Vaccines For Children (VFC) Sales by Country (2026-2031) & (K Doses)
 Table 28. North America Vaccines For Children (VFC) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Vaccines For Children (VFC) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Vaccines For Children (VFC) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Vaccines For Children (VFC) Sales by Country (2020-2025) & (K Doses)
 Table 32. Europe Vaccines For Children (VFC) Sales by Country (2026-2031) & (K Doses)
 Table 33. Europe Vaccines For Children (VFC) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Vaccines For Children (VFC) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Vaccines For Children (VFC) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Vaccines For Children (VFC) Sales by Region (2020-2025) & (K Doses)
 Table 37. Asia Pacific Vaccines For Children (VFC) Sales by Region (2026-2031) & (K Doses)
 Table 38. Asia Pacific Vaccines For Children (VFC) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Vaccines For Children (VFC) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Vaccines For Children (VFC) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Vaccines For Children (VFC) Sales by Country (2020-2025) & (K Doses)
 Table 42. Latin America Vaccines For Children (VFC) Sales by Country (2026-2031) & (K Doses)
 Table 43. Latin America Vaccines For Children (VFC) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Vaccines For Children (VFC) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Vaccines For Children (VFC) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Vaccines For Children (VFC) Sales by Country (2020-2025) & (K Doses)
 Table 47. Middle East and Africa Vaccines For Children (VFC) Sales by Country (2026-2031) & (K Doses)
 Table 48. Middle East and Africa Vaccines For Children (VFC) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Vaccines For Children (VFC) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Vaccines For Children (VFC) Sales (K Doses) by Type (2020-2025)
 Table 51. Global Vaccines For Children (VFC) Sales (K Doses) by Type (2026-2031)
 Table 52. Global Vaccines For Children (VFC) Sales Market Share by Type (2020-2025)
 Table 53. Global Vaccines For Children (VFC) Sales Market Share by Type (2026-2031)
 Table 54. Global Vaccines For Children (VFC) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Vaccines For Children (VFC) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Vaccines For Children (VFC) Revenue Market Share by Type (2020-2025)
 Table 57. Global Vaccines For Children (VFC) Revenue Market Share by Type (2026-2031)
 Table 58. Global Vaccines For Children (VFC) Price (US$/Dose) by Type (2020-2025)
 Table 59. Global Vaccines For Children (VFC) Price (US$/Dose) by Type (2026-2031)
 Table 60. Global Vaccines For Children (VFC) Sales (K Doses) by Application (2020-2025)
 Table 61. Global Vaccines For Children (VFC) Sales (K Doses) by Application (2026-2031)
 Table 62. Global Vaccines For Children (VFC) Sales Market Share by Application (2020-2025)
 Table 63. Global Vaccines For Children (VFC) Sales Market Share by Application (2026-2031)
 Table 64. Global Vaccines For Children (VFC) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Vaccines For Children (VFC) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Vaccines For Children (VFC) Revenue Market Share by Application (2020-2025)
 Table 67. Global Vaccines For Children (VFC) Revenue Market Share by Application (2026-2031)
 Table 68. Global Vaccines For Children (VFC) Price (US$/Dose) by Application (2020-2025)
 Table 69. Global Vaccines For Children (VFC) Price (US$/Dose) by Application (2026-2031)
 Table 70. GSK Company Information
 Table 71. GSK Description and Business Overview
 Table 72. GSK Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 73. GSK Vaccines For Children (VFC) Product
 Table 74. GSK Recent Developments/Updates
 Table 75. Sanofi Company Information
 Table 76. Sanofi Description and Business Overview
 Table 77. Sanofi Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 78. Sanofi Vaccines For Children (VFC) Product
 Table 79. Sanofi Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 83. Merck Vaccines For Children (VFC) Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 88. Pfizer Vaccines For Children (VFC) Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. Jintan Company Information
 Table 91. Jintan Description and Business Overview
 Table 92. Jintan Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 93. Jintan Vaccines For Children (VFC) Product
 Table 94. Jintan Recent Developments/Updates
 Table 95. CSL Company Information
 Table 96. CSL Description and Business Overview
 Table 97. CSL Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 98. CSL Vaccines For Children (VFC) Product
 Table 99. CSL Recent Developments/Updates
 Table 100. MedImmune LLC Company Information
 Table 101. MedImmune LLC Description and Business Overview
 Table 102. MedImmune LLC Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 103. MedImmune LLC Vaccines For Children (VFC) Product
 Table 104. MedImmune LLC Recent Developments/Updates
 Table 105. J&J(Crucell) Company Information
 Table 106. J&J(Crucell) Description and Business Overview
 Table 107. J&J(Crucell) Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 108. J&J(Crucell) Vaccines For Children (VFC) Product
 Table 109. J&J(Crucell) Recent Developments/Updates
 Table 110. China National Biotec Company Information
 Table 111. China National Biotec Description and Business Overview
 Table 112. China National Biotec Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 113. China National Biotec Vaccines For Children (VFC) Product
 Table 114. China National Biotec Recent Developments/Updates
 Table 115. Tiantan Company Information
 Table 116. Tiantan Description and Business Overview
 Table 117. Tiantan Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 118. Tiantan Vaccines For Children (VFC) Product
 Table 119. Tiantan Recent Developments/Updates
 Table 120. Hualan Company Information
 Table 121. Hualan Description and Business Overview
 Table 122. Hualan Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 123. Hualan Vaccines For Children (VFC) Product
 Table 124. Hualan Recent Developments/Updates
 Table 125. Kangtai Company Information
 Table 126. Kangtai Description and Business Overview
 Table 127. Kangtai Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 128. Kangtai Vaccines For Children (VFC) Product
 Table 129. Kangtai Recent Developments/Updates
 Table 130. Hissen Company Information
 Table 131. Hissen Description and Business Overview
 Table 132. Hissen Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 133. Hissen Vaccines For Children (VFC) Product
 Table 134. Hissen Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Vaccines For Children (VFC) Distributors List
 Table 138. Vaccines For Children (VFC) Customers List
 Table 139. Vaccines For Children (VFC) Market Trends
 Table 140. Vaccines For Children (VFC) Market Drivers
 Table 141. Vaccines For Children (VFC) Market Challenges
 Table 142. Vaccines For Children (VFC) Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Vaccines For Children (VFC)
 Figure 2. Global Vaccines For Children (VFC) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Vaccines For Children (VFC) Market Share by Type: 2024 & 2031
 Figure 4. Recombinant Vaccines Product Picture
 Figure 5. Viral Vaccines Product Picture
 Figure 6. Polysaccharide Vaccines Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Vaccines For Children (VFC) Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Vaccines For Children (VFC) Market Share by Application: 2024 & 2031
 Figure 10. Government Institution
 Figure 11. Private Sector
 Figure 12. Other
 Figure 13. Global Vaccines For Children (VFC) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Vaccines For Children (VFC) Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Vaccines For Children (VFC) Sales (2020-2031) & (K Doses)
 Figure 16. Global Vaccines For Children (VFC) Average Price (US$/Dose) & (2020-2031)
 Figure 17. Vaccines For Children (VFC) Report Years Considered
 Figure 18. Vaccines For Children (VFC) Sales Share by Manufacturers in 2024
 Figure 19. Global Vaccines For Children (VFC) Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Vaccines For Children (VFC) Players: Market Share by Revenue in Vaccines For Children (VFC) in 2024
 Figure 21. Vaccines For Children (VFC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Vaccines For Children (VFC) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Vaccines For Children (VFC) Sales Market Share by Country (2020-2031)
 Figure 24. North America Vaccines For Children (VFC) Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Vaccines For Children (VFC) Sales Market Share by Country (2020-2031)
 Figure 28. Europe Vaccines For Children (VFC) Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Vaccines For Children (VFC) Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Vaccines For Children (VFC) Revenue Market Share by Region (2020-2031)
 Figure 36. China Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Vaccines For Children (VFC) Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Vaccines For Children (VFC) Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Vaccines For Children (VFC) Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Vaccines For Children (VFC) Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Vaccines For Children (VFC) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Vaccines For Children (VFC) by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Vaccines For Children (VFC) by Type (2020-2031)
 Figure 58. Global Vaccines For Children (VFC) Price (US$/Dose) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Vaccines For Children (VFC) by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Vaccines For Children (VFC) by Application (2020-2031)
 Figure 61. Global Vaccines For Children (VFC) Price (US$/Dose) by Application (2020-2031)
 Figure 62. Vaccines For Children (VFC) Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Pediatric Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Paediatric Vaccine Market
Diphtheria Tetanus Pertussis Mix Vaccine for Children Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Preventable Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Ampoules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Combinations Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccines Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Bottle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pediatric Respiratory Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Viral Vaccines Market Research Report 2025
mRNA Vaccines for Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
23 valent Pneumococcal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ready to Use Therapeutic Food for Children Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plant based Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Quadrivalent Flu Vaccine Market Insights Forecast to 2030
Measles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Attenuated Vaccine Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions